Huperzine A
Huperzine A (Huperzia serrata extract) · also known as Huperzine A, Huperzine A
Huperzine A is a reversible acetylcholinesterase (AChE) inhibitor. After oral dosing in humans, red blood cell AChE activity is measurably suppressed. In vitro it can block the NMDA channel, but the concentrations needed are far above human plasma levels, so an NMDA effect at usual doses has not been confirmed.
Clinical uses and human evidence
Age-related cognitive decline
Memory
Mechanisms of action
Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)
Huperzine A is a reversible, selective AChE inhibitor that can reduce acetylcholine breakdown. In healthy older adults given escalating oral doses, red blood cell AChE activity was suppressed, with inhibition above 50% after the last 200 μg dose. But changes in peripheral enzyme activity do not equal quantitative changes in synaptic acetylcholine in the brain, and the latter has not been measured directly in humans.
GABA and glutamate balance (inhibitory and excitatory tone)
In vitro, huperzine A can block the NMDA channel, with an apparent Ki of about 6 μM. After a single 400 μg oral dose in humans, peak plasma concentration was only about 2.59 ng/mL, or about 11 nM. Brain concentration has not been measured directly, and an NMDA-blocking effect at usual doses has not been confirmed.